4
Changes in Ownership
Atea Pharmaceuticals, Inc. Filed Acc 0000899243-23-016127
Options or other derivatives
- Director acquired 79,900 shares (grant or award)
From the SEC's structured data for this filing
Trades in this filing
| Insider | Date | Transaction | Shares | Price | Value | Owned after | D/I |
|---|---|---|---|---|---|---|---|
| Derivatives | |||||||
| Duncan Barbara Gayle Director | 2023-06-16 | Grant or award · Restricted Stock Units | +33,150 | 33,150 | D | ||
| Duncan Barbara Gayle Director | 2023-06-16 | Grant or award · Stock Option (Right to Buy) | +46,750 | 46,750 | D | ||
Loading xslF345X04/doc4.xml…